2014
DOI: 10.1155/2014/204390
|View full text |Cite
|
Sign up to set email alerts
|

Vascular Aging across the Menopause Transition in Healthy Women

Abstract: Vascular aging, featuring endothelial dysfunction and large artery stiffening, is a major risk factor for developing cardiovascular disease (CVD). In women, vascular aging appears to be accelerated during the menopause transition, particularly around the late perimenopausal period, presumably related to declines in ovarian function and estrogen levels. The mechanisms underlying endothelial dysfunction and large artery stiffening with the menopause transition are not completely understood. Oxidative stress and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
57
0
3

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 74 publications
(64 citation statements)
references
References 115 publications
(140 reference statements)
1
57
0
3
Order By: Relevance
“…A reduction of LDL-c of 1.0 mmol/L was associated with a 22% decreased rate of major vascular events in an extensive meta-analysis of individual patient data [45], but this is difference is 2.5 to 10 times larger than menopause-related differences in this study or the study by Matthews et al [6], and in fact more approximate to the differences found with 20 years of chronological age. It may be that the increased risk of cardiovascular events observed in post-menopausal women, the causality of which is a matter of debate in itself [11, 12, 46], is mediated through other pathways such as oxidative stress and inflammation [47]. A previous proposal of lipid screening of women entering the menopausal transition [6] may therefore not prove beneficial.…”
Section: Discussionmentioning
confidence: 99%
“…A reduction of LDL-c of 1.0 mmol/L was associated with a 22% decreased rate of major vascular events in an extensive meta-analysis of individual patient data [45], but this is difference is 2.5 to 10 times larger than menopause-related differences in this study or the study by Matthews et al [6], and in fact more approximate to the differences found with 20 years of chronological age. It may be that the increased risk of cardiovascular events observed in post-menopausal women, the causality of which is a matter of debate in itself [11, 12, 46], is mediated through other pathways such as oxidative stress and inflammation [47]. A previous proposal of lipid screening of women entering the menopausal transition [6] may therefore not prove beneficial.…”
Section: Discussionmentioning
confidence: 99%
“…Due partially to low estrogen levels, postmenopausal women experience elevated inflammation, which may affect women’s health during aging [9395]. Indeed, estrogen typically inhibits inflammation, and inflammatory processes play a role in atherosclerosis, cardiovascular disease, and other age-related diseases later in life [94, 96, 97]. These complex relationships affect multiple other hormone mediators and neurotransmitters, providing promising targets for explaining sex differences in mood disorders [91].…”
Section: Discussionmentioning
confidence: 99%
“…Overproduction of ROS can affect endothelial function by suppressing nitric oxide synthesis and scavenging nitric oxide, decreasing its overall bioavailability. Moreover, OS due at least in part to the loss of the antioxidant effects of estrogen is a major contributor to the endothelial dysfunction observed in postmenopausal women (Moreau and Hildreth 2014).…”
Section: Introductionmentioning
confidence: 99%